Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer

Published:2015-04-18 Issue:8 Volume:4 Page:1171-1177
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Peixoto Renata D'Alpino¹²,Speers Caroline³,McGahan Colleen E.⁴,Renouf Daniel J.¹²,Schaeffer David F.²⁵,Kennecke Hagen F.¹²

Affiliation:

1. Division of Medical Oncology University of British Columbia British Columbia Cancer Agency Vancouver British Columbia Canada

2. Pancreas Centre Vancouver British Columbia Canada

3. Gastrointestinal Cancer Outcomes Unit British Columbia Cancer Agency Vancouver British Columbia Canada

4. Cancer Surveillance & Outcomes British Columbia Cancer Agency Vancouver British Columbia Canada

5. Department of Pathology and Laboratory Medicine University of British Columbia Vancouver British Columbia Canada

Funder

BC Cancer Foundation

BCCA Gastrointestinal Cancer Outcomes Unit

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.459

Reference30 articles.

1. Cancer statistics, 2014

2. The national cancer data base report on pancreatic cancer

3. Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement by Callery et al.

4. Phase III Trial of Gemcitabine Plus Tipifarnib Compared With Gemcitabine Plus Placebo in Advanced Pancreatic Cancer

5. Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Splenic rupture secondary to pancreatic malignancy invasion: A rare case;Trauma Case Reports;2024-09

2. Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma;The Oncologist;2024-07-16

3. Addressing disparities in health outcomes for patients with advanced pancreatic cancer and limited English proficiency;Asia-Pacific Journal of Clinical Oncology;2024-05-30

4. Identifying the Morphological and Molecular Features of a Cell-Based Orthotopic Pancreatic Cancer Mouse Model during Growth over Time;International Journal of Molecular Sciences;2024-05-22

5. REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer;Annals of Surgery;2024-02-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3